Roles of integrins in tumor angiogenesis and lymphangiogenesis - PubMed (original) (raw)
Review
Roles of integrins in tumor angiogenesis and lymphangiogenesis
Barbara Garmy-Susini et al. Lymphat Res Biol. 2008.
Abstract
The lifelong dedication of Dr. Judah Folkman to understand how tumors co-opt vasculature to promote tumor growth and spread resulted in the development of an astounding body of knowledge and development of new clinical therapeutics for cancer. Angiogenesis is a critical point in the development and dissemination of most human tumors. Tumor-associated lymphangiogenesis also plays an important role in mediating tumor spread to lymph nodes. The molecular regulations of these processes are complex, and many key molecular families have been implicated in the regulation of angiogenesis and lymphangiogenesis. By regulating cell-cell and cell-matrix contacts, integrins participate in blood and lymphatic vessel growth by promoting endothelial cell migration and survival. Understanding the underlying mechanisms by which integrins promote tumor-associated blood and lymphatic vessel development might provide important modalities for the therapeutic intervention of metastatic spread. This review focuses on the role of integrins in angiogenesis and lymphangiogenesis. Integrins represent potential targets for pharmacological agents and open new avenues for the control of metastatic spread in the treatment of malignancies. This article is dedicated to the memory of Dr. Judah Folkman, an amazing and caring teacher, scientist, physician, and friend.
Figures
FIG. 1
Mechanisms regulating angiogenesis and lymphangiogenesis. Tumor cells near pre-existing blood vessels secrete growth factors and chemokines such as VEGF-A, bFGF, and TNFα that stimulate quiescent vascular endothelium to enter the cell cycle. Tumors also secrete factors such as VEGF-C, VEGFD, or VEGF-A that stimulate the growth of new lymphatic vessels in the peritumoral space. These growth factors activate or upregulate expression of integrins such as α1β1, α2β1, α4β1, α5β1, and αvβ3 on blood vessels and α4β1, α9β1, and α1β1 on lymphatic vessels. Tumor derived VEGF-C also promotes new lymphatic vessel growth in draining lymph nodes. These integrins then promote endothelial cell migration and survival during invasion of tumor tissue, resulting in the creation of new vessels sprouts. The new blood vessels promote tumor growth by removing waste products and providing nutrients. These new blood and lymphatic vessels also provide an avenue for tumor metastasis. Lymphangiogenesis promotes metastasis to lymph nodes and, sometimes, more distant tissues such as lung, whereas angiogenesis promotes metastasis to local and distant sites, such as lung.
FIG. 2
Integrin family of adhesion receptors. Each integrin receptor heterodimer binds a specific set of endogenous ligands, which may include ligands in the ECM, soluble ligands, and ligands on other cell surfaces. Integrins are divalent cation-dependent heterodimeric membrane glycoproteins comprised of noncovalently associated α and β subunits. Each integrin subunit consists of an extracellular domain, a single transmembrane region, and a short (approximately 30 to 40 amino acids) cytoplasmic region. Upon ligand binding, a series of intracellular signaling events is initiated. These pathways are associated with enhanced cell proliferation, migration, and survival.
Similar articles
- Integrins in tumor angiogenesis and lymphangiogenesis.
Foubert P, Varner JA. Foubert P, et al. Methods Mol Biol. 2012;757:471-86. doi: 10.1007/978-1-61779-166-6_27. Methods Mol Biol. 2012. PMID: 21909928 Free PMC article. - Methods to study lymphatic vessel integrins.
Garmy-Susini B, Makale M, Fuster M, Varner JA. Garmy-Susini B, et al. Methods Enzymol. 2007;426:415-38. doi: 10.1016/S0076-6879(07)26018-5. Methods Enzymol. 2007. PMID: 17697894 Review. - Integrins and their extracellular matrix ligands in lymphangiogenesis and lymph node metastasis.
Chen J, Alexander JS, Orr AW. Chen J, et al. Int J Cell Biol. 2012;2012:853703. doi: 10.1155/2012/853703. Epub 2012 Feb 12. Int J Cell Biol. 2012. PMID: 22505936 Free PMC article. - Integrins in angiogenesis and lymphangiogenesis.
Avraamides CJ, Garmy-Susini B, Varner JA. Avraamides CJ, et al. Nat Rev Cancer. 2008 Aug;8(8):604-17. doi: 10.1038/nrc2353. Epub 2008 May 22. Nat Rev Cancer. 2008. PMID: 18497750 Free PMC article. Review. - Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
Tobler NE, Detmar M. Tobler NE, et al. J Leukoc Biol. 2006 Oct;80(4):691-6. doi: 10.1189/jlb.1105653. Epub 2006 Jun 22. J Leukoc Biol. 2006. PMID: 16793912 Review.
Cited by
- Oxidized laminin-1 induces increased monocyte attachment and expression of ICAM-1 in endothelial cells.
Kostidou E, Topouridou K, Daniilidis A, Kaloyianni M, Koliakos G. Kostidou E, et al. Int J Exp Pathol. 2009 Dec;90(6):630-7. doi: 10.1111/j.1365-2613.2009.00686.x. Int J Exp Pathol. 2009. PMID: 19958399 Free PMC article. - Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.
Vermorken JB, Guigay J, Mesia R, Trigo JM, Keilholz U, Kerber A, Bethe U, Picard M, Brummendorf TH. Vermorken JB, et al. Br J Cancer. 2011 May 24;104(11):1691-6. doi: 10.1038/bjc.2011.152. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540865 Free PMC article. Clinical Trial. - MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions.
Bazaa A, Pasquier E, Defilles C, Limam I, Kessentini-Zouari R, Kallech-Ziri O, El Battari A, Braguer D, El Ayeb M, Marrakchi N, Luis J. Bazaa A, et al. PLoS One. 2010 Apr 12;5(4):e10124. doi: 10.1371/journal.pone.0010124. PLoS One. 2010. PMID: 20405031 Free PMC article. - Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.
Hou Y, Bock F, Hos D, Cursiefen C. Hou Y, et al. Cells. 2021 Jul 2;10(7):1661. doi: 10.3390/cells10071661. Cells. 2021. PMID: 34359831 Free PMC article. Review. - Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A -308G>A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients.
Ban EZ, Lye MS, Chong PP, Yap YY, Lim SYC, Abdul Rahman H. Ban EZ, et al. PLoS One. 2018 Jun 18;13(6):e0198332. doi: 10.1371/journal.pone.0198332. eCollection 2018. PLoS One. 2018. PMID: 29912899 Free PMC article.
References
- Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936. - PubMed
- Dang DT, Chun SY, Burkitt K, Abe M, Chen S, Havre P, Mabjeesh NJ, Heath EI, Vogelzang NJ, Cruz–Correa M, Blayney DW, Ensminger WD, St Croix B, Dang NH, Dang LH. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res. 2008;68:1872–1880. - PubMed
- Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–732. - PubMed
- Klagsbrun M. Mediators of angiogenesis: The biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol. 1992;3:81–87. - PubMed
- Chen JX, Chen Y, DeBusk L, Lin W, Lin PC. Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis. Am J Physiol Heart Circ Physiol. 2004;287:H187–195. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA083133-01/CA/NCI NIH HHS/United States
- R01 CA126820/CA/NCI NIH HHS/United States
- R01 CA126820-01A1/CA/NCI NIH HHS/United States
- R01 CA098048-01/CA/NCI NIH HHS/United States
- CA98048/CA/NCI NIH HHS/United States
- R01 CA098048/CA/NCI NIH HHS/United States
- R01 CA083133/CA/NCI NIH HHS/United States
- CA126820/CA/NCI NIH HHS/United States
- CA83133/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources